These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 25073836)
1. Application site affects the pharmacokinetics of topical testosterone applied to the axilla compared with the inner arm. Davis SR; Evans AM; Humberstone A Clin Ther; 2014 Oct; 36(10):1395-401. PubMed ID: 25073836 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women. Fooladi E; Reuter SE; Bell RJ; Robinson PJ; Davis SR Menopause; 2015 Jan; 22(1):44-9. PubMed ID: 24845394 [TBL] [Abstract][Full Text] [Related]
3. Utility of a single serum testosterone measurement to determine response to topical testosterone replacement in hypogonadal men. Muram D; Ni X Curr Med Res Opin; 2016; 32(2):263-9. PubMed ID: 26549704 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study. Wang C; Berman N; Longstreth JA; Chuapoco B; Hull L; Steiner B; Faulkner S; Dudley RE; Swerdloff RS J Clin Endocrinol Metab; 2000 Mar; 85(3):964-9. PubMed ID: 10720024 [TBL] [Abstract][Full Text] [Related]
5. Effect of deodorant and antiperspirant use and presence or absence of axillary hair on absorption of testosterone 2% solution applied to men's axillae. Small DS; Ni X; Polzer P; Vart R; Satonin DK; Mitchell MI J Sex Med; 2014 Nov; 11(11):2809-17. PubMed ID: 25123988 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the steady-state pharmacokinetics, metabolism, and variability of a transdermal testosterone patch versus a transdermal testosterone gel in hypogonadal men. Mazer N; Bell D; Wu J; Fischer J; Cosgrove M; Eilers B; J Sex Med; 2005 Mar; 2(2):213-26. PubMed ID: 16422889 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of a novel testosterone matrix transdermal system in healthy, premenopausal women and women infected with the human immunodeficiency virus. Javanbakht M; Singh AB; Mazer NA; Beall G; Sinha-Hikim I; Shen R; Bhasin S J Clin Endocrinol Metab; 2000 Jul; 85(7):2395-401. PubMed ID: 10902784 [TBL] [Abstract][Full Text] [Related]
8. Transdermal testosterone administration in hypogonadal men: comparison of pharmacokinetics at different sites of application and at the first and fifth days of application. Yu Z; Gupta SK; Hwang SS; Cook DM; Duckett MJ; Atkinson LE J Clin Pharmacol; 1997 Dec; 37(12):1129-38. PubMed ID: 9506008 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioavailability of a new testosterone gel formulation in comparison to Testogel® in healthy men. Olsson H; Sandström R; Neijber A; Carrara D; Grundemar L Clin Pharmacol Drug Dev; 2014 Sep; 3(5):358-64. PubMed ID: 27129008 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site- -a clinical research center study. Meikle AW; Arver S; Dobs AS; Sanders SW; Rajaram L; Mazer NA J Clin Endocrinol Metab; 1996 May; 81(5):1832-40. PubMed ID: 8626843 [TBL] [Abstract][Full Text] [Related]
11. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. Swerdloff RS; Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Longstreth J; Berman N J Clin Endocrinol Metab; 2000 Dec; 85(12):4500-10. PubMed ID: 11134099 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of testosterone in hypogonadal men after transdermal delivery: influence of dose. Brocks DR; Meikle AW; Boike SC; Mazer NA; Zariffa N; Audet PR; Jorkasky DK J Clin Pharmacol; 1996 Aug; 36(8):732-9. PubMed ID: 8877678 [TBL] [Abstract][Full Text] [Related]
13. Effect of application site, clothing barrier, and application site washing on testosterone transfer with a 1.62% testosterone gel. Stahlman J; Britto M; Fitzpatrick S; McWhirter C; Testino SA; Brennan JJ; Zumbrunnen TL Curr Med Res Opin; 2012 Feb; 28(2):281-90. PubMed ID: 22188557 [TBL] [Abstract][Full Text] [Related]
14. Bioequivalence assessment of a single 5 mg/day testosterone transdermal system versus two 2.5 mg/day systems in hypogonadal men. Wilson DE; Meikle AW; Boike SC; Fairless AJ; Etheredge RC; Jorkasky DK J Clin Pharmacol; 1998 Jan; 38(1):54-9. PubMed ID: 9597560 [TBL] [Abstract][Full Text] [Related]
15. Testosterone pharmacokinetics after application of an investigational transdermal system in hypogonadal men. Yu Z; Gupta SK; Hwang SS; Kipnes MS; Mooradian AD; Snyder PJ; Atkinson LE J Clin Pharmacol; 1997 Dec; 37(12):1139-45. PubMed ID: 9506009 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of a single dose of buccal testosterone. Kim S; Snipes W; Hodgen GD; Anderson F Contraception; 1995 Nov; 52(5):313-6. PubMed ID: 8585889 [TBL] [Abstract][Full Text] [Related]
17. Effects of skin washing on systemic absorption of testosterone in hypogonadal males after administration of 1.62% testosterone gel. Stahlman J; Britto M; Fitzpatrick S; McWhirter C; Testino SA; Brennan JJ; Zumbrunnen TL Curr Med Res Opin; 2012 Feb; 28(2):271-9. PubMed ID: 22185431 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women. van Rooij K; Bloemers J; de Leede L; Goldstein I; Lentjes E; Koppeschaar H; Olivier B; Tuiten A Psychoneuroendocrinology; 2012 Jun; 37(6):773-81. PubMed ID: 21982723 [TBL] [Abstract][Full Text] [Related]
19. Transdermal testosterone gel: pharmacokinetics, efficacy of dosing and application site in hypogonadal men. Meikle AW; Matthias D; Hoffman AR BJU Int; 2004 Apr; 93(6):789-95. PubMed ID: 15049991 [TBL] [Abstract][Full Text] [Related]
20. Skin reactions in a phase 3 study of a testosterone topical solution applied to the axilla in hypogonadal men. Muram D; Melby T; Alles Kingshill E Curr Med Res Opin; 2012 May; 28(5):761-6. PubMed ID: 22458919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]